Áron Vincze

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Medicine, Internal Medicine, Pharmacology +8

Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn’s Disease After Ileocolonic Resection

Miguel Regueiro, Brian G. Feagan, Bin Zou et al. · Gastroenterology · 2016 · 329 citations · Full text

Medicine, Clinical Sciences, Surgery +14

Prospective, Multicentre, Nationwide Clinical Data from 600 Cases of Acute Pancreatitis

Andrea Párniczky, Balázs Kui, Andrea Szentesi et al. · PLoS ONE · 2016 · 257 citations · Full text

Medicine, Internal Medicine, Clinical Epidemiology +12

Efficacy and Safety of the Biosimilar Infliximab CT-P13 Treatment in Inflammatory Bowel Diseases: A Prospective, Multicentre, Nationwide Cohort

K Gecse, Barbara D. Lovász, Klaudia Farkas et al. · Journal of Crohn s and Colitis · 2015 · 183 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +12

Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn’s disease

László Kiss, Tamás Szamosi, Tamás Molnár et al. · Alimentary Pharmacology & Therapeutics · 2011 · 160 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17